RayzeBio logo

RayzeBio

San Diego, CA

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.

rayzebio.com

Company Details

Founded

2020

Employees

Between 100 - 500 employees

Raised

$418,000,000

Headquarters Location

San Diego, CA

Public

Yes

Acquired

Yes

Founders

Aron Knickerbocker
Aron Knickerbocker
Aaron Kantoff
Aaron Kantoff
Deborah Charych
Deborah Charych

Company Collections

These are collections RayzeBio is a part of. Click on the collection name to view similar companies.

RayzeBio's Industries

RayzeBio's Tech Stack

Company Collections For RayzeBio

RayzeBio Headquarters Location

5505 Morehouse Drive suite 300, San Diego, CA 92121

Total Amount Raised: $418,000,000

RayzeBio Funding Rounds

  • IPO

    Unknown

  • Series D

    $160,000,000

    Series D Investors

    Sofinnova Investments
    Viking Global Investors
    Wellington Management
    Sands Capital Management
    Laurion Capital Management
    Ally Bridge Group
    Soleus Capital

  • Series C

    $108,000,000

    Series C Investors

    Venrock Healthcare Capital Partners
    TCG Crossover Management
    Viking Global Investors
    Cormorant Asset Management
    Alexandria Venture Investments
    Acuta Capital Partners
    Versant Ventures
    Deerfield Management
    venBio Partners
    Vivo Capital
    Samsara BioCapital
    LifeSci Venture Partners
    Redmile Group
    OrbiMed Advisors
    Logos Capital
    Perceptive Advisors

  • Series B

    $105,000,000

    Series B Investors

    Venrock Healthcare Capital Partners
    venBio Partners
    Viking Global Investors
    Redmile Group
    OrbiMed Advisors
    Alexandria Venture Investments
    Samsara BioCapital
    Cormorant Asset Management
    Logos Capital
    LifeSci Venture Partners
    Versant Ventures

  • Series A

    $45,000,000

    Series A Investors

    venBio Partners
    Versant Ventures
    Samsara BioCapital
Funding info provided by Diffbot.

RayzeBio Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on RayzeBio.

Recent reviews